STRATA Skin Sciences Inc
NASDAQ:SSKN
Balance Sheet
Balance Sheet Decomposition
STRATA Skin Sciences Inc
STRATA Skin Sciences Inc
Balance Sheet
STRATA Skin Sciences Inc
| Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
19
|
9
|
19
|
15
|
30
|
31
|
28
|
8
|
4
|
11
|
3
|
4
|
4
|
16
|
8
|
11
|
13
|
5
|
7
|
7
|
|
| Cash Equivalents |
0
|
0
|
19
|
9
|
19
|
15
|
30
|
31
|
28
|
8
|
4
|
11
|
3
|
4
|
4
|
16
|
8
|
11
|
13
|
5
|
7
|
7
|
|
| Short-Term Investments |
0
|
7
|
0
|
12
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
3
|
4
|
3
|
3
|
4
|
4
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
3
|
4
|
3
|
3
|
4
|
4
|
5
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
5
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
6
|
3
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
8
|
8
|
0
|
2
|
2
|
2
|
|
| Total Current Assets |
0
|
7
|
19
|
22
|
21
|
16
|
30
|
31
|
29
|
10
|
10
|
17
|
12
|
11
|
11
|
23
|
24
|
25
|
20
|
18
|
16
|
17
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
7
|
4
|
2
|
14
|
10
|
8
|
5
|
7
|
7
|
8
|
8
|
12
|
11
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
0
|
4
|
2
|
14
|
10
|
8
|
5
|
7
|
7
|
8
|
8
|
12
|
11
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
0
|
5
|
5
|
6
|
7
|
11
|
14
|
16
|
18
|
20
|
22
|
24
|
26
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
13
|
12
|
10
|
8
|
6
|
10
|
17
|
7
|
5
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
7
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
7
|
3
|
|
| Total Assets |
0
N/A
|
7
+1 551%
|
19
+170%
|
22
+17%
|
22
-2%
|
17
-25%
|
32
+93%
|
34
+5%
|
31
-7%
|
17
-45%
|
14
-18%
|
20
+42%
|
50
+150%
|
43
-14%
|
39
-9%
|
48
+21%
|
47
0%
|
47
-1%
|
47
0%
|
52
+12%
|
42
-20%
|
36
-14%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
4
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
4
|
5
|
5
|
5
|
7
|
7
|
7
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
2
|
2
|
3
|
2
|
3
|
3
|
2
|
3
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
3
|
6
|
2
|
7
|
6
|
10
|
9
|
17
|
19
|
13
|
13
|
12
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
20
|
22
|
8
|
7
|
0
|
1
|
7
|
7
|
15
|
15
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
7
|
0
|
1
|
0
|
1
|
1
|
1
|
9
|
2
|
1
|
|
| Total Liabilities |
1
N/A
|
1
+6%
|
1
+33%
|
1
+26%
|
1
+16%
|
2
+14%
|
2
+18%
|
2
-1%
|
2
-11%
|
3
+107%
|
6
+78%
|
8
+33%
|
34
+336%
|
28
-16%
|
19
-32%
|
16
-16%
|
19
+15%
|
21
+12%
|
21
+1%
|
30
+44%
|
29
-4%
|
31
+6%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
5
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
14
|
21
|
31
|
43
|
61
|
79
|
99
|
120
|
142
|
168
|
182
|
207
|
211
|
204
|
211
|
215
|
219
|
222
|
227
|
238
|
248
|
|
| Additional Paid In Capital |
5
|
10
|
39
|
53
|
64
|
76
|
110
|
131
|
149
|
156
|
176
|
195
|
223
|
225
|
224
|
242
|
243
|
245
|
247
|
249
|
251
|
253
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
6
N/A
|
18
+185%
|
21
+17%
|
21
-3%
|
15
-27%
|
30
+101%
|
32
+5%
|
30
-6%
|
14
-53%
|
8
-41%
|
12
+48%
|
16
+31%
|
15
-9%
|
20
+35%
|
31
+57%
|
29
-8%
|
26
-10%
|
25
-2%
|
22
-14%
|
13
-42%
|
5
-61%
|
|
| Total Liabilities & Equity |
0
N/A
|
7
+1 551%
|
19
+170%
|
22
+17%
|
22
-2%
|
17
-25%
|
32
+93%
|
34
+5%
|
31
-7%
|
17
-45%
|
14
-18%
|
20
+42%
|
50
+150%
|
43
-14%
|
39
-9%
|
48
+21%
|
47
0%
|
47
-1%
|
47
0%
|
52
+12%
|
42
-20%
|
36
-14%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
4
|
30
|
33
|
34
|
34
|
35
|
4
|
4
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|